key: cord-0790937-j6xs5kel
authors: Lee, Jacqueline C.; Kawwass, Jennifer F.
title: COVID19 infection in pregnancy: a Spanish perspective of spontaneous and IVF pregnancies
date: 2021-07-10
journal: Fertil Steril
DOI: 10.1016/j.fertnstert.2021.06.054
sha: 3ace715970ee606174c6769d7acd24c413e9a17b
doc_id: 790937
cord_uid: j6xs5kel

Limited data highlights high rates of cesarean delivery in COVID-19 infected patients who conceived with IVF; additional robust studies are needed to evaluate COVID-19 impact on perinatal outcomes.

Editorial title: COVID19 infection in pregnancy: a Spanish perspective of spontaneous and IVF pregnancies As we continue to learn more about the adverse effects of SARS-CoV-2 infection on perinatal outcomes, it is important to understand whether specific groups of pregnant women, including those that conceive using assisted reproductive technology (ART), are more vulnerable to these consequences. Patients who conceived after in vitro fertilization (IVF) are known to be at a relative increased risk for adverse perinatal outcomes including hypertensive disorders of pregnancy, low birthweight delivery, gestational diabetes mellitus, and preterm and operative delivery. While the absolute risk of these adverse outcomes remains low, it is essential to educate patients about the potential additional risks of conception and subsequent pregnancy complicated by SARS-COV-2 infection amidst an ongoing global pandemic.

In this prospective, multicenter, observational study by Calvo et. al., authors aim to describe the perinatal and maternal outcomes of pregnancies in symptomatic and asymptomatic women infected with SARS-CoV-2. They separate pregnancies by method of conception (spontaneous vs. IVF) and by oocyte source (autologous vs. donor) in patients that conceived after IVF. During the study period 1,347 pregnant women found to be positive for SARS-CoV-2 by polymerase chain reaction testing were identified and registered. Seventy-four (5.5%) of these patients conceived by IVF. Authors found no difference in disease severity by mode of conception. The rate of cesarean delivery in IVF-conceived pregnancies was 55.4%, most commonly due to induction failure. Using multivariable regression analysis and controlling for maternal age and clinical presentation for infection, authors found higher rate of cesarean delivery in the IVF group. Moreover, infected women who conceived by IVF had higher rate of ICU admission which was attributed to a higher rate of hypertensive disorders of pregnancy.

This study is strengthened by its size; it includes a large group of pregnant women infected with SARS-CoV-2 and appropriately stratifies them by method of conception and oocyte source among those who underwent IVF. The prospective nature of this study allowed for robust data collection and the tables aptly describe the cohort's baseline characteristics and perinatal outcomes.

The authors highlight differences in IVF and spontaneously conceived pregnancies, specifically rate of cesarean delivery and hypertensive disorders of pregnancy [2] . Though the reported rate of cesarean delivery rate in IVF conceived pregnancies in this study is well above stated World Health Organization's ideal rate of 10-15%, the authors do not report the baseline cesarean delivery rate in this population prior to the pandemic, or the rate of cesarean delivery among patients not infected with SARS-CoV-2 who delivered during this time period limiting conclusions [3] . Inclusion of only symptomatic patients without universal screening also introduces significant risk of selection bias. Additionally, the authors use logistic regression but control only for maternal age and clinical presentation of infection. It is important to consider additional confounders when comparing spontaneous and ART pregnancies, including race, rate of multiple gestation, gestational age, among others.

The ideal study investigating perinatal outcomes in SARS-CoV-2 positive patients would not only identify patients at the time of infection and track perinatal outcomes, but also follow uninfected matched controls who experience pregnancy and delivery in the same clinical context and environment to better understand the correlations between infection and pregnancy outcomes. Furthermore, it is important to identify patients at different stages of reproduction with SARS-CoV-2 infection, including preconception, early pregnancy, peripartum, and postpartum.

We have much more to learn about the effect of COVID-19 on the health and wellbeing of pregnant women, including those that conceive with IVF. We must acknowledge the limitations of our current data and strive to better understand more about how COVID-19 can modify pregnancy outcomes at all stages of reproduction so that we can protect our patients and be informed advocates for systemic vaccination in this population. Data regarding implications of infection during pregnancy may also inform future scenarios in which preconception and pregnant patients are faced with another coronavirus infection. As we continue to strive for safe provision of ART, we look forward to more prospective research that can enhance our knowledge and guide our practice, including published peerreviewed studies from ongoing pregnancy registries and vaccine surveillance systems including the University of California San Francisco ASPIRE study and the Centers for Disease Control and Prevention COVID19 Pregnancy and V-safe registries.

Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2 infected women: a prospective observational study

Committee Opinion No 671: Perinatal Risks associated with Assisted Reproductive Technology

World Health Organization. WHO Statement on Cesarean Section Rates